Multiplexed testing in the autoimmunity laboratory

Clinical Chemistry and Laboratory Medicine

Volumn 44, Issue 10, 2006, Pages 1169-1174

  González Buitrago, José M ^a,b  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^b UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Antigen microarray; Antinuclear antibodies; Autoantibody; Autoimmune diseases; Multiplexed tests

Indexed keywords

AUTOANTIBODY; NANOPARTICLE;

ANTIBODY DETECTION; AUTOIMMUNE DISEASE; AUTOIMMUNITY; FLOW CYTOMETRY; HUMAN; IMMUNOASSAY; LABORATORY TEST; MEDICAL TECHNOLOGY; MICROARRAY ANALYSIS; PRIORITY JOURNAL; REVIEW;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CLINICAL CHEMISTRY TESTS; FLOW CYTOMETRY; HUMANS; IMMUNOASSAY; MICROARRAY ANALYSIS;

EID: 33750072919     PISSN: 14346621     EISSN: 14346621     Source Type: Journal    
DOI: 10.1515/CCLM.2006.213     Document Type: Review

References (35)

1. Davidson A, Diamond B. Autoimmune diseases. N Engl J Med 2001;345:340-50.
2. Marrack P, Kappler J, Kotzin BL. Autoimmune disease: why and where it occurs. Nature Med 2001;7:899-905.
3. Hochberg M. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
4. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander E, Carsons SE, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European consensus group. Ann Rheum Dis 2002;61:554-8.
5. Sherer Y, Gorstein A, Fritzler MJ, Shoenfeld Y. Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. Semin Arthritis Rheum 2004;34:501-37.
6. Arbuckle MR, James JA, Dennis GJ, Rubertone HV, McClain MT, Kim XR, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003;349:1526-33.
7. Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Chase HP, et al. Number of autoantibodies (against insulin, GAD or ICA512/IA2) rather than particular autoantibody specificities determines risk of type I diabetes. J Autoimmun 1996;9:379-83.
8. González-Buitrago JM, González C. Present and future of the autoimmunity laboratory. Clin Chim Acta 2006;365:50-7.
9. Meheus L, van Venrooij WJ, Wiik A, Charles PJ, Tzioufas AG, Meyer O, et al. Multicenter validation of recombinant, natural and synthetic antigens in a single multiparameter assay for the detection of specific antinuclear autoantibodies in connective tissue disorders. Clin Exp Rheumatol 1999;17:205-14.
10. Pottel H, Wiik A, Locht H, Gordon T, Roberts-Thomson P, Abraham O, et al. Clinical optimization and multicenter validation of antigen-specific cut-off values on the INNO-LIA ANA update for the detection of autoantibodies to connective tissue disorders. Clin Exp Rheumatol 2004;22:579-88.
11. Damoiseaux J, Boesten K, Giesen J, Austen J, Cohen Tervaert JW. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens. Ann NY Acad Sci 2005;1050:340-7.
12. Eissfeller P, Sticherling M, Scholz D, Hennig K, Lüttich T, Motz M, et al. Comparison of different test system for simultaneous autoantibody detection in connective tissue diseases. Ann NY Acad Sci 2005;1050:327-39.
13. Penn SG, He L, Natan MJ. Nanoparticles for bioanalysis. Curr Opin Chem Biol 2003;7:609-15.
14. Smith J, Onley D, Garey C, Crowther S, Cahir N, Johanson A, et al. Determination of ANA specificity using the UltraPlex™ Platform. Ann NY Acad Sci 2005;1050:286-94.
15. Rouquette AM, Desgruelles C, Laroche P. Evaluation of the new multiplexed immunoassay, FIDIS, for simultaneous quantitative determination of antinuclear antibodies and comparison with conventional methods. Am J Clin Pathol 2003;120:676-81.
16. Buliard A, Fortenfant F, Ghillani-Dalbin P, Musset L, Oksman F, Olsson NO. [Analysis of nine autoantibodies associated with systemic autoimmune diseases using the Luminex technology. Results of a multicenter study]. Ann Biol Clin (Paris) 2005;63:51-8.
17. Martins TB, Burlingame R, von Muhlen CA, Jaskowski TD, Litwin CM, Hill HR. Evaluation of multiplexed fluorescent microsphere immunoassay for detection of autoantibodies to nuclear antigens. Clin Diagn Lab Immunol 2004;11:1054-9.
18. Gilburd B, Abu-Shakra M, Shoenfeld Y, Giordano A, Bocci EB, delle Monache F, et al. Autoantibodies profile in the sera of patients with Sjögren's syndrome: the ANA evaluation - a homogeneous, multiplexed system. Clin Dev Immunol 2004;11:53-6.
19. Shovman O, Gilburd B, Zandman-Goddard G, Yehiely A, Langevitz P, Shoenfeld Y. Multiplexed Athena Multi-Lyte immunoassay for ANA screening in autoimmune diseases. Autoimmunity 2005;38:105-9.
20. Zandman-Goddard G, Gilburd B, Showman O, Blank M, Berdichevski S, Langevitz P, et al. The homogeneous multiplexed system - a new method for autoantibody profile in systemic lupus erythematosus. Clin Dev Immunol 2005;12:107-11.
21. Nifli AP, Notas G, Mamoulaki M, Niniraki M, Ampartzaki V, Theodoropoulos PA, et al. Comparison of a multiplex, bead-based fluorescent assay and immunofluorescence methods for the detection of ANA and ANCA autoantibodies in human serum. J Immunol Methods 2006;311:189-97.
22. Shovman O, Gilburd B, Barzilai O, Shinar E, Larida B, Zandman-Goddard G, et al. Evaluation of the BioPlex™ 2200 ANA screen. Analysis of 510 healthy subjects: incidence of natural/predictive autoantibodies. Ann NY Acad Sci 2005;1050:380-8.
23. Gonzalez C, García-Berrocal B, Talaván T, Casas ML, Navajo JA, González-Buitrago JM. Clinical evaluation of a microsphere bead-based flow cytometry assay for the simultaneous determination of anti-thyroid peroxidase and anti-thyroglobulin antibodies. Clin Biochem 2005;38:966-72.
24. Balboni I, Chan SM, Kattah M, Tenenbaum JD, Butte AJ, Utz PJ. Multiplexed protein array platforms for analysis of autoimmune diseases. Annu Rev Immunol 2006;24:391-418.
25. Joos TO, Schrenk M, Höpfl P, Kroger K, Chowdhury U, Stoll D, et al. A microarray enzyme-linked immunosorbent assay for autoimmune diagnostics. Electrophoresis 2000;21:2641-50.
26. Robinson WH, DiGennaro C, Hueber W, Haab BB, Kamachi M, Dean EJ, et al. Autoantigen microarrays for multiplex characterisation of autoantibody responses. Nat Med 2002;8:295-301.
27. Hueber W, Kidd BA, Tomooka BH, Lee BJ, Bruce B, Fries JF. Antigen microarray profiling of autoantibodies in rheumatoid arthritis. Arthritis Rheum 2005; 52:2645-55.
28. Feng Y, Ke X, Ma R, Chen Y, Hu G, Lu F. Parallel detection of autoantibodies with microarrays in rheumatoid diseases. Clin Chem 2004;50:416-22.
29. Robinson WH, Steinman L, Utz PJ. Proteomics technologies for the study of autoimmune disease. Arthritis Rheum 2002;46:855-93.
30. Hueber W, Utz PJ, Steinman L, Robinson WH. Autoantibody profiling for the study and treatment of autoimmune disease. Arthritis Res 2002;4:290-5.
31. Robinson WH, Steinman L, Utz PJ. Protein and peptide array analysis of autoimmune disease. Biotechniques 2002;33:S66-9.
32. Robinson WH, Utz PJ, Steinman L. Genomic and proteomic analysis of multiple sclerosis. Opinion. Curr Opin Immunol 2003;15:660-7.
33. Robinson WH, Steinman L, Utz PJ. Protein arrays for autoantibody profiling and fine-specificity mapping. Proteomics 2003;3:2077-84.
34. Graham KL, Robinson WH, Steinman L, Utz PJ. High-throughput methods for measuring autoantibodies in systemic lupus erythematosus and other autoimmune diseases. Autoimmunity 2004;37:269-72.
35. Robinson WH. Antigen arrays for autoantibody profiling. Curr Opin Chem Biol 2006;10:67-72.